COVID-19 Mass Vaccination Resource Calculator

Abstract

Background Despite the recent emergency use authorization of two vaccines for the prevention of the 2019 novel coronavirus (COVID-19) disease, vaccination rates are lower than expected. Vaccination efforts may be hampered by supply, delivery, storage, patient prioritization, administration infrastructure or logistics problems. To address the last issue, our institution is sharing publically a calculator to optimize the management of staffing and facility resources in an outpatient mass vaccination effort.

Objective By sharing our calculator locally and through this paper, we aim to help health organizations administering vaccines optimize resource allocation while maximizing efficiency.

Methods Our calculator determines the maximum number of vaccinations that can be administered per hour, the number of check-in staff (clerks) needed, the number of vaccination staff (nurses) needed, and the required room capacity needed for the vaccination and the mandatory 15-minute observation period after inoculation.

Results We provide a functional version of the calculator, allowing users to replicate the calculation for their own vaccine events.

Conclusion An efficient and organized vaccination program is critical to halting the spread of COVID-19. By sharing this calculator, it is our hope that other organizations may use it to facilitate rapid and efficient vaccination.

Keywords

COVID-19 - vaccine - vaccination methods - scheduling tools - resource management and tracking

Protection of Human and Animal Subjects

We did not conduct human and animal subject research in this study.

Publication History

Received: 11 February 2021

Accepted: 25 June 2021

Article published online:
18 August 2021

• References

• 1 Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 Vaccination Program. JAMA 2020; 323 (24) 2458-2459
• 2 Jesus EGd. How does the newly authorized Moderna COVID-19 vaccine compare to Pfizer's? Sci News 2020. Accessed 2021 at: https://www.sciencenews.org/article/covid-19-coronavirus-moderna-vaccine-fda-approval
• 3 Prevention CfDCa. CDC COVID data tracker. Accessed 2021 at: https://covid.cdc.gov/covid-data-tracker/-vaccinations
• 4 Santora M. Vaccine rollouts in europe are off to a Shaky Start, even as lockdowns expand. The New York Times. Accessed 2021 at: https://www.nytimes.com/2021/01/05/world/europe/europe-covid-vaccinations.html
• 5 Else H. How a torrent of COVID science changed research publishing in seven charts. Nature. Accessed 2021 at: https://www.nature.com/articles/d41586-020-03564-y
• 6 Cabanillas B, Akdis C, Novak N. Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?. Allergy 2021; 76 (06) 1617-1618
• 7 Mills MC, Salisbury D. The challenges of distributing COVID-19 vaccinations. EClinicalMedicine 2021; 31: 100674
• 8 COVID-19 Vaccination Program Interim Operational Guidance Jurisdiction Operations. Centers for Disease Control and Prevention. Published October 29, 2020. Accessed April 9, 2021 at: https://www.cdc.gov/vaccines/imz-managers/downloads/Covid-19-Vaccination-Program-Interim_Playbook.pdf
• 9 Weintraub RL, Subramanian L, Karlage A, Ahmad I, Rosenberg J. COVID-19 vaccine to vaccination: why leaders must invest in delivery strategies now. Health Aff (Millwood) 2021; 40 (01) 33-41
• 10 Pre-Vaccination Clinic Activities. Centers for disease control and prevention. Published August 11, 2020. Accessed April 9, 2021 at: https://www.cdc.gov/vaccines/hcp/admin/mass-clinic-activities/pre-clinic-activities.html